Clinical Trials in Los Angeles

Showing 361-380 of 8,055 trials

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

NCT07161544

The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease secondary to a biallelic mutation of the ABCA4 gene. The study will also assess initial efficacy following AAVB-039 administration.

Stargardt Disease

AAVantgarde Bio Srl75 participantsStarted Sep 2025

Los Angeles, California, United States • Rochester, Minnesota, United States • Bellaire, Texas, United States +3 more locations

COMPLETEDPHASE1< 1 mile

Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

NCT06285214

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.

Interstitial Cystitis/Bladder Pain Syndrome

Imbrium Therapeutics47 participantsStarted May 2022

Homewood, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +21 more locations

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

Find Trials by Condition in Los Angeles

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

SuperSaturated Oxygen Comprehensive Observational Registry

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Abemaciclib and Letrozole to Treat Endometrial Cancer